149 related articles for article (PubMed ID: 31427562)
1. SOX18 Affects Cell Viability, Migration, Invasiveness, and Apoptosis in Hepatocellular Carcinoma (HCC) Cells by Participating in Epithelial-to-Mesenchymal Transition (EMT) Progression and Adenosine Monophosphate Activated Protein Kinase (AMPK)/Mammalian Target of Rapamycin (mTOR).
Sun Y; Lei B; Huang Q
Med Sci Monit; 2019 Aug; 25():6244-6254. PubMed ID: 31427562
[TBL] [Abstract][Full Text] [Related]
2. Piezoeletric cold atmospheric plasma induces apoptosis and autophagy in human hepatocellular carcinoma cells through blocking glycolysis and AKT/mTOR/HIF-1α pathway.
Wang Y; Mang X; Li D; Chen Y; Cai Z; Tan F
Free Radic Biol Med; 2023 Nov; 208():134-152. PubMed ID: 37543168
[TBL] [Abstract][Full Text] [Related]
3. Role of pelitinib in the regulation of migration and invasion of hepatocellular carcinoma cells via inhibition of Twist1.
Lee S; Kang E; Lee U; Cho S
BMC Cancer; 2023 Jul; 23(1):703. PubMed ID: 37495969
[TBL] [Abstract][Full Text] [Related]
4. NOD-like receptor X1 functions as a tumor suppressor by inhibiting epithelial-mesenchymal transition and inducing aging in hepatocellular carcinoma cells.
Hu B; Ding GY; Fu PY; Zhu XD; Ji Y; Shi GM; Shen YH; Cai JB; Yang Z; Zhou J; Fan J; Sun HC; Kuang M; Huang C
J Hematol Oncol; 2018 Feb; 11(1):28. PubMed ID: 29482578
[TBL] [Abstract][Full Text] [Related]
5. FOXA2 plays a critical role in hepatocellular carcinoma progression and lenvatinib-associated drug resistance.
Wang Z; Shen J; Chen C; Wen T; Li C
Biosci Trends; 2023 May; 17(2):136-147. PubMed ID: 36823043
[TBL] [Abstract][Full Text] [Related]
6. CD146 promotes metastasis and predicts poor prognosis of hepatocellular carcinoma.
Jiang G; Zhang L; Zhu Q; Bai D; Zhang C; Wang X
J Exp Clin Cancer Res; 2016 Feb; 35():38. PubMed ID: 26928402
[TBL] [Abstract][Full Text] [Related]
7. MLXIPL promotes the migration, invasion, and glycolysis of hepatocellular carcinoma cells by phosphorylation of mTOR.
Chang X; Tian C; Jia Y; Cai Y; Yan P
BMC Cancer; 2023 Feb; 23(1):176. PubMed ID: 36809979
[TBL] [Abstract][Full Text] [Related]
8. HOXB13 facilitates hepatocellular carcinoma progression by activating AKT/mTOR signaling pathway.
Li M; Tan T; Geng Y; Tao Y; Pan J; Zhang J; Xu Q; Shen H; Zuo L; Chen Y
Ann Hepatol; 2023; 28(1):100759. PubMed ID: 36179794
[TBL] [Abstract][Full Text] [Related]
9. Bigelovin inhibits hepatocellular carcinoma cell growth and metastasis by regulating the MAPT-mediated Fas/FasL pathway.
Wang B; Nie CH; Xu J; Wan DL; Xu X; He JJ
Neoplasma; 2023 Apr; 70(2):208-215. PubMed ID: 36812233
[TBL] [Abstract][Full Text] [Related]
10. Gamabufotalin Induces Apoptosis and Cytoprotective Autophagy through the mTOR Signaling Pathway in Hepatocellular Carcinoma.
Liu L; Shi D; Xia ZY; Wang BW; Wang XL; Wang XT; Wang GL; Li MJ; Zheng QS; Li D; Li BH
J Nat Prod; 2023 Apr; 86(4):966-978. PubMed ID: 37043698
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Rk1 induces autophagy-dependent apoptosis in hepatocellular carcinoma by AMPK/mTOR signaling pathway.
Wu H; Qu L; Bai X; Zhu C; Liu Y; Duan Z; Liu H; Fu R; Fan D
Food Chem Toxicol; 2024 Apr; 186():114587. PubMed ID: 38461953
[TBL] [Abstract][Full Text] [Related]
12. CDCA2 Promotes HCC Cells Development via AKT-mTOR Pathway.
Li K; Fan T; Shi Z; Jiang H
Anal Cell Pathol (Amst); 2022; 2022():9912254. PubMed ID: 36588796
[TBL] [Abstract][Full Text] [Related]
13. SOS1 regulates HCC cell epithelial-mesenchymal transition via the PI3K/AKT/mTOR pathway.
Li Y; Yin Y; He Y; He K; Li J
Biochem Biophys Res Commun; 2022 Dec; 637():161-169. PubMed ID: 36403479
[TBL] [Abstract][Full Text] [Related]
14. Equilibrative nucleoside transporter 3 promotes the progression of hepatocellular carcinoma by regulating the AKT/mTOR signaling pathway.
Qin P; Yan J; Huang H; Wang Q; Li M; Zhang Y; Wang J; Jiang T; Zhang X; Zhou Y
Int J Biol Macromol; 2023 Jun; 241():124323. PubMed ID: 37023875
[TBL] [Abstract][Full Text] [Related]
15. Loss of WNK1 Suppressed the Malignant Behaviors of Hepatocellular Carcinoma Cells by Promoting Autophagy and Activating AMPK Pathway.
Wang F; Yan X; Shi G; Zhang L; Jing X
Dis Markers; 2022; 2022():6831224. PubMed ID: 36618969
[TBL] [Abstract][Full Text] [Related]
16. Lipophagy-related gene RAB7A is involved in immune regulation and malignant progression in hepatocellular carcinoma.
Liu Y; Ma J; Wang X; Liu P; Cai C; Han Y; Zeng S; Feng Z; Shen H
Comput Biol Med; 2023 May; 158():106862. PubMed ID: 37044053
[TBL] [Abstract][Full Text] [Related]
17. A traditional prescription comprising Astragali Radix and Schisandra chinensis Fructus induces apoptosis and protective autophagy in hepatocellular carcinoma cells.
Zhu PL; Li JK; Jiang XL; Zhang SQ; Zhang Z; Wang Y; Zhang Z; Chen WQ; Yung KK
J Ethnopharmacol; 2023 Aug; 312():116548. PubMed ID: 37100264
[TBL] [Abstract][Full Text] [Related]
18. Plectin Downregulation Inhibits Migration and Suppresses Epithelial Mesenchymal Transformation of Hepatocellular Carcinoma Cells via ERK1/2 Signaling.
Xu R; He S; Ma D; Liang R; Luo Q; Song G
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613521
[TBL] [Abstract][Full Text] [Related]
19. USP14 exhibits high expression levels in hepatocellular carcinoma and plays a crucial role in promoting the growth of liver cancer cells through the HK2/AKT/P62 axis.
Zhang N; Zhang H; Yang X; Xue Q; Wang Q; Chang R; Zhu L; Chen Z; Liu X
BMC Cancer; 2024 Feb; 24(1):237. PubMed ID: 38383348
[TBL] [Abstract][Full Text] [Related]
20. SSNA1 Promotes Hepatocellular Carcinoma Metastasis
Wu LW; Hu X
Anticancer Res; 2023 Aug; 43(8):3479-3486. PubMed ID: 37500134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
